CHEK2 and breast cancer: The BC risk associated to CHEK2 mutation carriership only doubles in such families and a significant fraction of BC patients do not carry the CHEK2 mutation.15, 16 Consequently, many authors proposed that BC predisposition in CHEK2 families occurs according to a polygenic model.